International journal of women's health · 2026
Bidirectional and Multivariable Mendelian Randomization Study of PCOS and VTE.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
You Lifang, Cui Hongyin, Zhao Fen, Huang Hairong, Xu Wenxuan
Аннотация
BACKGROUND: We used bidirectional and multivariable Mendelian randomization (MR) to test whether polycystic ovary syndrome (PCOS) is causally related to venous thromboembolism (VTE).
METHODS: Using European-ancestry GWAS summary statistics, we performed bidirectional two-sample univariable MR and multivariable MR adjusting for diabetes, body mass index (BMI), hormone replacement therapy, and oral contraceptive use. Robustness was assessed with Cochran's Q, MR-Egger intercept, MR-PRESSO, and leave-one-out analyses.
RESULTS: Univariable MR showed no causal effect of PCOS on VTE (IVW OR 1.008, 95% CI 0.974-1.042; p = 0.653), and reverse-direction MR provided no evidence that VTE causally influences PCOS. In multivariable MR, PCOS remained not associated with VTE (IVW OR 1.016, 95% CI 0.987-1.045; p = 0.285), whereas BMI had a clear independent positive effect on VTE risk (IVW OR 1.358, 95% CI 1.262-1.461; p < 0.001).
CONCLUSION: Genetic evidence does not support a causal relationship between PCOS and VTE. BMI is independently associated with VTE risk and appears to be a key determinant of VTE risk.
METHODS: Using European-ancestry GWAS summary statistics, we performed bidirectional two-sample univariable MR and multivariable MR adjusting for diabetes, body mass index (BMI), hormone replacement therapy, and oral contraceptive use. Robustness was assessed with Cochran's Q, MR-Egger intercept, MR-PRESSO, and leave-one-out analyses.
RESULTS: Univariable MR showed no causal effect of PCOS on VTE (IVW OR 1.008, 95% CI 0.974-1.042; p = 0.653), and reverse-direction MR provided no evidence that VTE causally influences PCOS. In multivariable MR, PCOS remained not associated with VTE (IVW OR 1.016, 95% CI 0.987-1.045; p = 0.285), whereas BMI had a clear independent positive effect on VTE risk (IVW OR 1.358, 95% CI 1.262-1.461; p < 0.001).
CONCLUSION: Genetic evidence does not support a causal relationship between PCOS and VTE. BMI is independently associated with VTE risk and appears to be a key determinant of VTE risk.